Our Discovery Research Grants support projects that will generate knowledge to underpin the discovery of treatments for hearing loss or tinnitus, or improve how new treatments are developed and tested.
We would like to particularly encourage applications this year in the areas of tinnitus, and medical devices to treat hearing loss.
See our Biomedical Research Strategy for more information.
Summary of Grant
Deadline for preliminary application
Monday 25 March 2024.
Full application
By invitation only
Duration
Up to 3 years
Eligibility
Applicants may be from any university or research institute based anywhere in the world
Value
Up to £225,000 in total, funding will not exceed £75,000 in one year.
In 2023, we received 69 preliminary applications. Of these, 25 applicants were invited to submit a full application. The outcome of this round of funding will be announced in March 2024 (4 projects expected).
Application process
The application procedure for the Discovery Research Grant has 2 stages, an open preliminary application stage followed by an invitation-only full application stage. Please see the call and guidelines below for further details.
All applications should be submitted via our online grants management system, Flexi-Grant. There’s guidance on Flexi-Grant about how to complete your application.
You can download the call and guidelines for 2024, our standard terms and conditions (subject to review), and a guide to using Flexi-Grant
- Discovery Research Grant call and guidelines 2024 (PDF, 211 KB)
- Discovery Research Grant standard terms and conditions (PDF, 356 KB)
- Flexi-Grant user guide (PDF, 222 KB)
Selection procedure
Preliminary applications are assessed by our Discovery Research Grant review panel; they will identify the best proposals to take forward to the full application stage.
Full applications are sent to at least two external referees in the field, who are asked to rate the scientific value and feasibility of the project. Applicants will be given the opportunity to respond to the external peer reviews. The reviews, rebuttals and the original proposals are then rated by members of our Discovery Research Grant review panel. The top-rated applications are funded. Applicants are notified of the outcome as soon as possible following the final decision.
Everyone involved in the review process of any grant application is asked to abide by our code of conduct.
Review panel
- Professor René Gifford, Vanderbilt University (chair)
- Professor Graham Naylor, University of Nottingham
- Dr Gwenaelle Géléoc, Boston Children’s Hospital
- Dr Sally Dawson, University College London
- Dr Conny Kopp-Scheinpflug, , Ludwig-Maximilians University, Munich
- Professor Berthold Langguth, University Hospital of Regensburg
- Dr Mahmood Bhutta, Brighton and Sussex University Hospitals NHS Trust
- Dr Zoe Mann, King’s College London
- Dr Alexander V. Galazyuk, Northeast Ohio Medical University
- 2 members to be recruited
Europe PubMed Central (Europe PMC) and open access publications
RNID is a member of the Europe PMC Funders’ Group. We support open access publications and require RNID grant holders to make their publications open access.
Read our open access publication policy for more information and visit the Europe PMC website.
For more information
If you would like more information about the Discovery Research Grant, please get in touch:
- Telephone
- +44 (0)20 3227 6158